Scynexis (SCYX) Net Margin (2013 - 2026)
Scynexis' (SCYX) quarterly Net Margin came in at 65.74% in Q4 2025, up 52449.0% YoY from N/an in Q4 2024, and up 102.56% on a QoQ basis from 2572.16% in Q3 2025.
Scynexis (SCYX) Net Margin (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 11 years of Net Margin data on file, last reported at 65.74% in Q4 2025.
- Quarterly Net Margin rose 52449.0% year-over-year to 65.74% in Q4 2025, while the trailing twelve-month figure through Mar 2026 was 96.57% (up 93533.0% YoY) and the FY2025 annual result came in at 41.79%, up 52781.0% from the prior year.
- Net Margin climbed to 65.74% in Q4 2025, from 2572.16% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 93.01% in Q2 2023 to a low of 4904.02% in Q4 2021.
- A 5-year average of 1122.42% and a median of 504.77% in 2025 frame the typical range for Net Margin.
- Annual changes were most pronounced in 2022 — Net Margin surged 362456 bps — and 2023, when it plunged 221916 bps.
- Tracing SCYX's Net Margin over 5 years: stood at 4904.02% in 2021, then jumped by 74 bps to 1279.46% in 2022, then surged by 71 bps to 366.84% in 2023, then retreated by 25 bps to 458.75% in 2024, then soared by 114 bps to 65.74% in 2025.
- The last three Net Margin figures came in at 65.74% (Q4 2025), 2572.16% (Q3 2025), and 504.77% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -13.91% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 35.09% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 9.28% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 42.51% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -3.16% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 15.06% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.95% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - | -3,017.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3,017.02% |
| Dec 31, 2025 | 65.74% |
| Sep 30, 2025 | -2,572.16% |
| Jun 30, 2025 | -504.77% |
| Mar 31, 2025 | -2,097.67% |
| Dec 31, 2024 | -458.75% |
| Sep 30, 2024 | -425.45% |
| Jun 30, 2024 | -1,964.40% |
| Mar 31, 2024 | 29.93% |
| Dec 31, 2023 | -366.84% |
| Sep 30, 2023 | -99.77% |
| Jun 30, 2023 | 93.01% |
| Mar 31, 2023 | -2,997.88% |
| Dec 31, 2022 | -1,279.46% |
| Sep 30, 2022 | -1,900.06% |
| Jun 30, 2022 | -1,008.69% |
| Mar 31, 2022 | -778.71% |
| Dec 31, 2021 | -4,904.02% |
| Sep 30, 2021 | -117.25% |
| Mar 31, 2021 | -38.80% |